home >  Projects >  Project 5 Development of innovative pharmaceuticals and medical technologies using biomedical resources in Tsukuba

Project 5 Development of innovative pharmaceuticals and medical technologies using biomedical resources in Tsukuba

Development of innovative pharmaceuticals and medical technologies using biomedical resources in Tsukuba
Tsukuba has a world-class repository of biomedical resources. We are developing innovative pharmaceuticals and medical technologies for treating intractable and rare diseases as well as cancers and epidemic diseases, by taking advantage of it.

Studies

  • Construction of a common platform of biomedical resources (2012-2013)
  • Establishment of the Consortium of Biomedical Resources (2013)
  • Clinical research and R&D for innovative medicines (2013-)
  • Clinical trials and pharmaceutical applications of innovative medicines (2016-)
  • Marketing of innovative medicines (2017-)

Main institutes involved: University of Tsukuba, National Institute of Advanced Industrial Science and Technology,
Eisai Co., Ltd., RIKEN BioResource Center, National Institute of Biomedical Innovation, and Cell-Medicine, Inc.


Back to Top